Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.
about
New and emerging targeted therapies for cystic fibrosisCorrection of chloride transport and mislocalization of CFTR protein by vardenafil in the gastrointestinal tract of cystic fibrosis miceInactivation of multidrug resistance proteins disrupts both cellular extrusion and intracellular degradation of cAMPPharmacokinetics and tolerability of oral sildenafil in adults with cystic fibrosis lung diseasePotential of anti-inflammatory treatment for cystic fibrosis lung disease.Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicityRepairing mutated proteins--development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator.Ligand responses of Vfr, the virulence factor regulator from Pseudomonas aeruginosa.Strategies in early clinical development for the treatment of basic defects of cystic fibrosis.ENaC is regulated by natriuretic peptide receptor-dependent cGMP signaling.PDE5 Inhibitors as Potential Tools in the Treatment of Cystic Fibrosis.SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion
P2860
Q26749278-10639010-5D4E-4C66-BCE5-673139CB53FBQ27303954-68FC9652-8F84-4D62-9ED6-1CB15F1EE467Q35122818-83106DE6-2D42-4AEB-AC89-907B0C9837C0Q35164509-56D9FF18-279A-475E-B111-79B727709177Q35557381-FDD8987B-AF99-4048-840E-A6DD32B26CE7Q36072775-274E1306-AA6A-4B50-82DF-9AB880C7FBE5Q38097952-7D6570EC-ED1A-49EE-9BE7-1D0DDE893C63Q38285657-6367A084-1245-4719-9821-3D4116C1DE71Q38733938-9372AF52-62B9-4C5A-B2D7-B188AB1CAC02Q39209577-AADF6CD7-0365-46EF-890F-ACC641443E76Q42325938-885D36DB-2DFD-4109-8B75-BDB79E7D8D83Q56535583-B762D3C2-4DBB-4396-AC77-B996C4F54303
P2860
Pharmacological modulation of cGMP levels by phosphodiesterase 5 inhibitors as a therapeutic strategy for treatment of respiratory pathology in cystic fibrosis.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Pharmacological modulation of ...... pathology in cystic fibrosis.
@en
type
label
Pharmacological modulation of ...... pathology in cystic fibrosis.
@en
prefLabel
Pharmacological modulation of ...... pathology in cystic fibrosis.
@en
P2093
P2860
P1476
Pharmacological modulation of ...... pathology in cystic fibrosis.
@en
P2093
Elizabeth Perkett
Graham S Timmins
Hongwei D Yu
Hugo R de Jonge
Jennifer L Taylor-Cousar
Jens F Poschet
Joseph Fazio
Kari R Wilson
Vojo Deretic
Wojciech Ornatowski
P2860
P304
P356
10.1152/AJPLUNG.00314.2006
P577
2007-06-22T00:00:00Z